Clinical updates, including trial initiations, enrollment status and data readouts and publications: Apellis, Brainstorm, Celldex, Chiesi Farmaceutici, Disc Medicine, Eli Lilly, Eyepoint, Gensight, Humacyte, Ironwood, Johnson & Johnson, Kalvista, Novartis, Recce, Urogen, Vera, Vivoryon.